Non-invasive Vagal Nerve Stimulation as Novel Treatment to Improve Functional Outcomes in Veterans With Alcohol Use Disorder
Conditions: Alcohol Use Disorder Interventions: Device: Cervical transcutaneous vagus nerve stimulation (active comparator); Device: Cervical transcutaneous vagus nerve stimulation (sham comparator) Sponsors: VA Office of Research and Development Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2024 Category: Research Source Type: clinical trials
Public Health Initiative on Alcohol Flushing
Conditions: Alcohol Toxicity Interventions: Genetic: ALDH2 Genotyping Sponsors: Stanford University; Stanford Center for Asian Health Research and Education Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2024 Category: Research Source Type: clinical trials
12-Step Facilitation/MET/CBT (InTEGRA) vs. MET/CBT for Youth With Alcohol and Other Drug Use Disorder: A Multisite RCT
Conditions: Alcohol Use Disorder; Cannabis Use Disorder Interventions: Behavioral: InTEGRA; Behavioral: MET/CBT Sponsors: Massachusetts General Hospital; National Institute on Alcohol Abuse and Alcoholism (NIAAA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 2, 2024 Category: Research Source Type: clinical trials
Online Intervention for Transgender/Nonbinary Young Adults' Experiences With Alcohol and Romantic Relationships
Conditions: Alcohol Use, Unspecified; Relationship, Social; Depression, Anxiety; Transgenderism Interventions: Behavioral: Whole Selves Sponsors: Boston University; National Institute on Alcohol Abuse and Alcoholism (NIAAA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2024 Category: Research Source Type: clinical trials
Centering Gender Affirming Resources in Higher Education
Conditions: Sexual Violence; Drinking Heavy Interventions: Behavioral: Giving Information for Trauma Support and Safety (GIFTSS) Training; Behavioral: Centering gender Affirming Resources in higher Education (CARE) Learning Modules Sponsors: University of Pittsburgh; National Institute on Alcohol Abuse and Alcoholism (NIAAA) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2024 Category: Research Source Type: clinical trials
EndoNAFLD: Relationship Between Fatty Liver Disease and Cardiovascular Diseases
Conditions: Non-Alcoholic Fatty Liver Disease; Cardiovascular Diseases Sponsors: IMDEA Food; Sociedad Espa ñola de Arteriosclerosis; Clinica Universidad de Navarra, Universidad de Navarra; Hospital HM Montepríncipe; Hospital Central de la Defensa Gómez Ulla; Hospital Universitario 12 de Octubre Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2024 Category: Research Source Type: clinical trials
Cardiac Dysfunction in Patients With Non-alcoholic Fatty Liver Disease
Conditions: NAFLD; Cardiac Disease; Fatty Liver Interventions: Diagnostic Test: Echocardiographic assessment Sponsors: Post Graduate Institute of Medical Education and Research, Chandigarh Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2024 Category: Research Source Type: clinical trials
Personalized Approach Bias Modification in Heavy Drinking Veterans With Mild to Moderate Traumatic Brain Injury
Conditions: Alcohol Use Disorder; Mild-Moderate Traumatic Brain Injury Interventions: Behavioral: Personalized VR Alcohol Approach Bias Modification (ApBM) Condition; Behavioral: Sham Condition Sponsors: VA Office of Research and Development Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2024 Category: Research Source Type: clinical trials
Peer Support in Alcohol Dependence
Conditions: Alcohol Use Disorder Interventions: Behavioral: Quality life questionnaire AQoLS; Behavioral: Quality life questionnaire Euroqol EQ-5D-5L; Other: Peer support consultations Sponsors: Hospices Civils de Lyon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2024 Category: Research Source Type: clinical trials
Effectiveness of Screening and Decolonization of S. Aureus to Prevent S. Aureus Surgical Site Infections in Surgery Outpatients
Conditions: Staphylococcus Aureus Colonization; Surgical Site Infections; Healthcare Associated Infections Interventions: Other: Screening and decolonization for SA carriers with the 3 drug bundle; Other: No screening for SA; Other: no screening; Other: Nasal povidone-iodine on surgery day plus 2 CHG pre-op showers without screening.; Other: Nasal alcohol gel on surgery day plus 2 CHG pre-op showers without screening Sponsors: University of Minnesota Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2024 Category: Research Source Type: clinical trials
Effect of Multi-ingredient on Visceral Adiposity & Non-alcoholic Fatty Liver Disease in Postmenopausal Women With Abdominal Obesity
Conditions: Visceral Obesity; Non-alcoholic Fatty Liver; Postmenopausal Interventions: Dietary Supplement: Multi-ingredient of L-histidine, L-serine, L-carnosine and N-Acetylcysteine; Dietary Supplement: Placebo Sponsors: Fundaci ó Eurecat; Centre de Diagnosi per la Imatge; Instituto de Investigación Biomédica de Girona (IDIBGI); Laboratorio de Referencia de Cataluña Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2024 Category: Research Source Type: clinical trials
The translocator protein 18kDa ligand etifoxine in the treatment of depressive disorders —a double-blind, randomized, placebo-controlled proof-of-concept study
This study will provide a first proof-of-concept on the potential of the TSPO ligand etifoxine in the treatment of depressive disorders.Trial registrationClinical Trials Register (EudraCT number:2021-006773-38, registration date: 14 September 2022) and German Register of Clinical Studies (DRKS number:DRKS00031099, registration date: 23 January 2023). (Source: Trials)
Source: Trials - April 22, 2024 Category: Research Source Type: clinical trials
Fibrosis Lessens After Metabolic Surgery
Conditions: Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD); Non-Alcoholic Fatty Liver Disease; Metabolic Dysfunction-Associated Steatohepatitis (MASH); Liver Fibrosis; Obesity Interventions: Procedure: Metabolic surgery; Drug: Incretin-Based Therapy Sponsors: Ali Aminian Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2024 Category: Research Source Type: clinical trials
MASLD in Primary Hypothyroidism and Efficacy of Dapaglifozin
Conditions: Hepatic Steato-Fibrosis; Non-Alcoholic Fatty Liver Disease Interventions: Drug: Dapagliflozin 10mg Tab; Drug: Placebo; Drug: Levothyroxine Replacement daily Sponsors: Post Graduate Institute of Medical Education and Research, Chandigarh Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Imaging Traumatic Stress and Alcohol Use Disorder With [18F]Bavarostat
Conditions: Alcohol Use Disorder; Post Traumatic Stress Disorder Interventions: Drug: Bavarostat Sponsors: Yale University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
